Depo-provera and Mucosal inflammation - a phase IV clinical study of FDA data

Summary:

Mucosal inflammation is reported as a side effect among people who take Depo-provera (medroxyprogesterone acetate), especially for people who are female, 40-49 old, also take Zofran, and have Eczema.

The phase IV clinical study analyzes which people have Mucosal inflammation when taking Depo-provera. It is created by eHealthMe based on reports of 15,804 people who have side effects when taking Depo-provera from the FDA, and is updated regularly.

What is Depo-provera?

Depo-provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 17,093 Depo-provera users. Check the latest studies of Depo-provera.

What is Mucosal inflammation?

Mucosal inflammation (infection of mucous membrane) is found to be associated with 1,192 drugs and 1,241 conditions by eHealthMe. Check the latest studies of Mucosal inflammation.

On Aug, 11, 2026

15,804 people reported to have side effects when taking Depo-provera.
Among them, 14 people (0.09%) have Mucosal inflammation.

Could Depo-provera cause Mucosal inflammation?

Among these 14 people:

What is the gender of people who have Mucosal inflammation when taking Depo-provera? *

female: 100 %
male: 0.0 %

What is the age of people who have Mucosal inflammation when taking Depo-provera? *

What are other drugs people take besides Depo-provera? *

Zofran: 12 people, 85.71%
Percocet: 10 people, 71.43%
Neulasta: 10 people, 71.43%
Lorazepam: 10 people, 71.43%
Hydrocodone Bitartrate And Acetaminophen: 10 people, 71.43%
Emla: 10 people, 71.43%
Elidel: 10 people, 71.43%
Effexor: 10 people, 71.43%
Dilaudid: 10 people, 71.43%
Compazine: 10 people, 71.43%

What are other side effects people have besides Mucosal inflammation? *

Swallowing Difficulty: 11 people, 78.57%
Joint Pain: 10 people, 71.43%
Sinusitis (inflammation of sinus): 10 people, 71.43%
Migraine (headache): 10 people, 71.43%
Pain In Jaw: 10 people, 71.43%
Lymphoedema (localized fluid retention and tissue swelling): 10 people, 71.43%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 10 people, 71.43%
Pneumonia Staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus): 10 people, 71.43%
Intervertebral Disc Protrusion (spinal disc protrusion): 10 people, 71.43%
Bone Pain: 10 people, 71.43%

What are the existing conditions these people have? *

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 10 people, 71.43%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 7.14%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Depo-provera and have Mucosal inflammation?

- Check whether Mucosal inflammation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Depo-provera:

Depo-provera (17,093 reports)

Browse all side effects of Depo-provera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mucosal inflammation:

Mucosal inflammation (1,192 drugs)

Browse all the conditions that are associated with Mucosal inflammation:

Mucosal inflammation (1,241 conditions)

Related publications that referenced our studies

Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .
Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on medroxyprogesterone acetate (the active ingredients of Depo-provera) and Depo-provera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.